Drugs of abuse in urine - screening
Product Code
PT-DU-SCREEN-W
Proficiency Testing Scheme
Matrix
Industry Sector/s
Product Format
3 x 15ml lyophilized human urine. This is designed for participants who report using immunoassay type techniques, including POCT (point of care testing).
Accreditation
ISO/IEC 17043
Overview of PT samples and distribution dates:
Product Information
Analyte Data
Analyte Name
Range
Units
Accreditation
Amfetamines screen
-
μg/L
Barbiturates Screen
-
μg/L
Benzodiazepines screen
-
μg/L
Buprenorphine and Metabolite Screen
-
μg/L
Cannabinoid Screen
-
μg/L
Cocaine and Metabolite Screen
-
μg/L
EDDP Screen
-
μg/L
LSD and Metabolite Screen
-
μg/L
Methadone Screen
-
μg/L
Opiates screen
-
μg/L
Phencyclidine Screen
-
μg/L
Propoxyphene and Metabolite Screen
-
μg/L
Screening-only membership = screening only analytes using immunoassay type techniques. For Clinical and EWDTS thresholds, please see the DAU Scheme Description.
For details on the full technical specification of the scheme, please refer to the Scheme Description.